Sam-e vs. 5 htp: side effect and effectiveness comparison - a phase IV clinical study
We compare the side effects and drug effectiveness of Sam-e and 5 htp. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 1,904 people who take Sam-e and 5 htp, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,904 people who take Sam-e and 5 htp are studied.
What is Sam-e?
Sam-e has active ingredients of same. It is often used in depression. eHealthMe is studying from 264 Sam-e users for its effectiveness, alternative drugs and more.
What is 5 htp?
5 htp has active ingredients of 5 - htp. It is often used in depression. eHealthMe is studying from 244 5 htp users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- 5 Htp (5 - htp)
- Sam-E (same)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
- not at all: 3.42 %
- somewhat: 14.53 %
- moderate: 30.77 %
- high: 45.3 %
- very high: 5.98 %
- not at all: 8.43 %
- somewhat: 27.71 %
- moderate: 40.96 %
- high: 13.86 %
- very high: 9.04 %
Want to compare Sam-e with 5 htp?Personalize this study to your gender and age (0-99+).
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of:
How the study uses the data?
The study is based on same and 5 - htp (the active ingredients of Sam-e and 5 htp, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Kevzara and Eyelid Twitch - 4 seconds ago
- Prednisone and Prochlorperazine Edisylate drug interaction - 5 seconds ago
- Tremfya and Ulcerative Colitis - 7 seconds ago
- Fiorinal vs. Methylprednisolone - 14 seconds ago
- Diovan Hct vs. Simvastatin - 18 seconds ago
- Valium and Weight Increased - 19 seconds ago
- Synthroid and Blisovi Fe 1/20 drug interaction - 21 seconds ago
- Bacillus Probiotics vs. Elavil - 31 seconds ago
- Amlodipine and Diclofenac Sodium drug interaction - 37 seconds ago
- Penicillin V Potassium and Meclizine drug interaction - 49 seconds ago